描述遗传性阿尔法三血病患者的临床特征和治疗过程:单中心研究
Meghan Matheny1, Maria P Henao1, Taha Al-Shaikhly2
1Section of Allergy, Pennsylvania State University School of Medicine, Asthma & Immunology, Hershey, PA, USA.
Clinical reviews in allergy & immunology
|June 14, 2025
概括
遗传性alpha-tryptasemia (HαT) 与严重的过敏反应和POTS和GERD等并发症有关. 三倍化基因型与更高的超移动性和POTS患病率相关,这表明HαT需要进一步调查.
科学领域:
- 医学遗传学 医学遗传学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 遗传性α-tryptasemia (HαT) 与过敏反应的风险和严重程度增加有关.
- 已经指出了HαT与超运动,POTS和GERD等疾病之间的联系,但没有明确的生物化学或遗传联系.
研究的目的:
- 描述医疗系统内HαT患者的临床表现,治疗和并发症.
- 分析具有HαT基因型 (2α3β,3α2β) 的患者的特征.
主要方法:
- 对被诊断患有HαT的患者进行了回顾性的横截面图表审查.
- 分析临床数据,治疗和同时出现的诊断.
主要成果:
- 26.9%的HαT患者患有高移动性或POTS; 57.7%患有GERD.
- 在26.9%的患者中发生过敏反应.
- HαT三倍化基因型与更高的超流动性和POTS率有关,以及使用oomalizumab或cromolyn的增加.
结论:
- 在患有冲,尿疹或过敏反应的患者中,同时出现的超流动性,POTS和GERD应该促使HαT调查.
- HαT基因型 (三倍化) 影响并发病率和治疗选择.
相关概念视频
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Hypertension III: Clinical Manifestations and Diagnostic Studies
886
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
886
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
764
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764


![Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)